Lund, Sweden

Per Antonsson


Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 230(Granted Patents)


Company Filing History:


Years Active: 2003-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Per Antonsson: Innovator in Cancer Treatment

Introduction

Per Antonsson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of cancer treatment through his innovative approaches and patented technologies. With a total of 4 patents, Antonsson's work focuses on the development of methods and compositions that enhance therapeutic options for cancer patients.

Latest Patents

Among his latest patents, Antonsson has developed methods for treating subjects with cancer by administering a conjugate between a variant staphylococcal enterotoxin E superantigen and an antibody that binds to the 5T4 antigen. This invention relates to compositions and methods of use, wherein the composition comprises a conjugate of a bacterial superantigen and an antibody moiety. The bacterial superantigen has been modified to decrease seroreactivity while retaining superantigen activity. Another significant patent involves modified chimeric superantigens, characterized by a conjugate between a target-seeking moiety and a modified superantigen. This superantigen retains the ability to activate a subset of T cells while having undergone specific amino acid modifications. Additionally, he has developed a therapeutic method utilizing these modified/chimeric superantigens.

Career Highlights

Throughout his career, Antonsson has worked with prominent companies in the biotechnology sector, including Active Biotech AB and Pharmacia AB. His experience in these organizations has allowed him to refine his expertise in developing innovative cancer therapies.

Collaborations

Antonsson has collaborated with notable colleagues such as Mikael Dohlsten and Johan Hansson. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Per Antonsson's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents reflect a commitment to improving therapeutic options for patients, showcasing the importance of research and collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…